These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2457)

  • 1. Failure to monoaminergic and cholinergic receptor blockers to prevent prostaglandin E2-induced luteinizing hormone release.
    Harms PG; Ojeda SR; McCann
    Endocrinology; 1976 Feb; 98(2):318-23. PubMed ID: 2457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of neurotransmitter blockers to alter PGE2-induced LH release.
    Jyujo T; Sato T
    Endocrinol Jpn; 1977 Aug; 23(4):281-7. PubMed ID: 200413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on prostaglandin E2 (PGE2)-induced gonadotropin release: comparison with the effect of 15-methyl PGE2, PGAs, PGBs and prostaglandin endoperoxide analogs.
    Ojeda SR; Jameson HE; McCann SM
    Prostaglandins; 1976 Aug; 12(2):281, 301. PubMed ID: 959591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of neurotransmitter blockers to alter PGE2-induced LH release.
    Jyujo T; Sato T
    Endocrinol Jpn; 1976 Aug; 23(4):281-7. PubMed ID: 14822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2-induced release of LHRH into hypophysial portal blood(1).
    Eskay RL; Warberg J; Mical RS; Porter JC
    Endocrinology; 1975 Oct; 97(4):816-24. PubMed ID: 1104351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for involvement of alpha-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence.
    Ojeda SR; Negro-Vilar A; McCann SM
    Endocrinology; 1982 Feb; 110(2):409-12. PubMed ID: 6276133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic areas involved in prostaglandin (PG)-induced gonadotropin release. I: effects of PGE2 and PGF2alpha implants on luteinizing hormone release.
    Ojeda SR; Jameson HE; McCann SM
    Endocrinology; 1977 Jun; 100(6):1585-94. PubMed ID: 870307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenaline and prostaglandin E2 stimulate LH-RH release from rat median eminence through distinct 1-alpha-adrenergic and PGE2 receptors.
    Heaulme M; Dray F
    Neuroendocrinology; 1984 Nov; 39(5):403-7. PubMed ID: 6096749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhibitors of prostaglandin synthesis on gonadotropin release in the rat.
    Ojeda SR; Harms PG; McCann SM
    Endocrinology; 1975 Oct; 97(4):843-54. PubMed ID: 1193009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2-induced release of luteinizing hormone-releasing factor (LRF).
    Ojeda SR; Wheaton JE; McCann SM
    Neuroendocrinology; 1975; 17(3):283-7. PubMed ID: 1095952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adrenergic blocking drugs on secretion of luteinizing hormone in the ovariectomized ewe.
    Jackson GL
    Biol Reprod; 1977 May; 16(4):543-8. PubMed ID: 15666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between neuropeptide Y and adrenergic systems in the stimulation of luteinizing hormone release in steroid-primed ovariectomized rats.
    Allen LG; Crowley WR; Kalra SP
    Endocrinology; 1987 Dec; 121(6):1953-9. PubMed ID: 2824175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of estradiol and LHRH on LH release in rhesus females: evidence for a neural site of action.
    Spies HG; Norman RL
    Endocrinology; 1975 Sep; 97(3):685-92. PubMed ID: 809257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin stimulates luteinizing hormone-releasing hormone secretion from arcuate nucleus-median eminence fragments in vitro: involvement of an alpha-adrenergic mechanism.
    Lopez FJ; Negro-Vilar A
    Endocrinology; 1990 Nov; 127(5):2431-6. PubMed ID: 1699747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct action of prostaglandins on the rat pituitary.
    Sato T; Hirono M; Jyujo T; Iesaka T; Taya K
    Endocrinology; 1975 Jan; 96(1):45-9. PubMed ID: 1089062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic areas involved in prostaglandin (PG)-induced gonadotropin release. II: effect of PGE2 and PGF2alpha implants on follicle stimulating hormone release.
    Ojeda SR; Jameson HE; McCann SM
    Endocrinology; 1977 Jun; 100(6):1595-603. PubMed ID: 870308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats.
    Tsukamura H; Nagatani S; Cagampang FR; Kawakami S; Maeda K
    Endocrinology; 1994 Mar; 134(3):1460-6. PubMed ID: 8119187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prostaglandin-enhanced release of LH by antiserum to luteinizing hormone releasing hormone.
    Eskay RL; Warberg J; Porter JC
    Neuroendocrinology; 1977; 24(5-6):353-8. PubMed ID: 347326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of beta-endorphin-induced blockade of ovulation and luteinizing hormone surge with prostaglandin E2.
    Leadem CA; Kalra SP
    Endocrinology; 1985 Aug; 117(2):684-9. PubMed ID: 3160573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.